- Home
- KYMR vs BANR Comparison
KYMR vs BANR Comparison
Compare KYMR & BANR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KYMR
- BANR
- Stock Information
- Founded
- KYMR 2015
- BANR 1890
- Country
- KYMR United States
- BANR United States
- Employees
- KYMR N/A
- BANR N/A
- Industry
- KYMR Medicinal Chemicals and Botanical Products
- BANR Major Banks
- Sector
- KYMR Health Care
- BANR Finance
- Exchange
- KYMR Nasdaq
- BANR Nasdaq
- Market Cap
- KYMR 2.2B
- BANR 2.3B
- IPO Year
- KYMR 2020
- BANR 1995
- Fundamental
- Price
- KYMR $25.97
- BANR $60.49
- Analyst Decision
- KYMR Buy
- BANR Buy
- Analyst Count
- KYMR 13
- BANR 6
- Target Price
- KYMR $56.69
- BANR $73.80
- AVG Volume (30 Days)
- KYMR 847.3K
- BANR 273.5K
- Earning Date
- KYMR 05-01-2025
- BANR 04-16-2025
- Dividend Yield
- KYMR N/A
- BANR 3.17%
- EPS Growth
- KYMR N/A
- BANR 5.82
- EPS
- KYMR N/A
- BANR 5.09
- Revenue
- KYMR $47,072,000.00
- BANR $614,045,000.00
- Revenue This Year
- KYMR $16.24
- BANR N/A
- Revenue Next Year
- KYMR $22.41
- BANR $5.69
- P/E Ratio
- KYMR N/A
- BANR $11.89
- Revenue Growth
- KYMR N/A
- BANR 3.98
- 52 Week Low
- KYMR $19.45
- BANR $42.00
- 52 Week High
- KYMR $53.27
- BANR $78.05
- Technical
- Relative Strength Index (RSI)
- KYMR 44.70
- BANR 46.98
- Support Level
- KYMR $24.43
- BANR $54.82
- Resistance Level
- KYMR $26.06
- BANR $60.99
- Average True Range (ATR)
- KYMR 2.36
- BANR 3.24
- MACD
- KYMR 0.41
- BANR 0.20
- Stochastic Oscillator
- KYMR 70.12
- BANR 60.39
About KYMR Kymera Therapeutics Inc.
Kymera Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to reinventing the treatment of human disease through the development of, differentiated medicines that address health problems and that meaningfully improve patients' lives. It is committed to novel technologies to address targets that have known disease-causing biology, but which have not been drugged, or have been inadequately drugged, often based on limitations of existing technologies. Its approach is intended to discover and develop a new generation of medicines in a disease-agnostic manner. Its product pipelines are STAT6, TYK2, and IRAK4.
About BANR Banner Corporation
Banner Corp is a bank holding company. It wholly owns one subsidiary bank, Banner Bank. The Bank's primary business is that of traditional banking institutions, accepting deposits and originating loans in locations surrounding its offices in Washington, Oregon, California, Idaho and Utah. Banner Bank also actively participates in the secondary loan markets, engaging in mortgage banking operations largely through the origination and sale of one to four family residential loans.